Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19

Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. Severe acute respiratory syndrome-coronavirus-2, a novel coronavirus that causes coronavirus disease-2019 (COVID-19), has been associated with an increased risk of thrombosis. We describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Marginean, Alexandru, Masic, Dalila, Brailovsky, Yevgeniy, Fareed, Jawed, Darki, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Thromboembolic Events
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236704/
https://www.ncbi.nlm.nih.gov/pubmed/32835283
http://dx.doi.org/10.1016/j.jaccas.2020.05.017
Descripción
Sumario:Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. Severe acute respiratory syndrome-coronavirus-2, a novel coronavirus that causes coronavirus disease-2019 (COVID-19), has been associated with an increased risk of thrombosis. We describe the therapeutic challenges of 3 patients presenting with PE and suspected or confirmed COVID-19. (Level of Difficulty: Beginner.)

Ejemplares similares